Sergi Mas

2.7k citations

115 papers · 1.8k indexed · h-index 25

Impact in

Biological Psychiatry top 2%
- Tryptophan and brain disorders
Psychiatry and Mental health top 2%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment

Papers in ⓘ

Psychiatry and Mental health 43
- Schizophrenia research and treatment 32
- Bipolar Disorder and Treatment 23
Molecular Biology 35

Co-authors: Patricia Gassó (87 shared papers)Amàlia Lafuente (76 shared papers)Miquel Bernardo (51 shared papers)Eduard Parellada (26 shared papers)Luisa Lázaro (25 shared papers)Natàlia Rodríguez (43 shared papers)Anna Crescenti (13 shared papers)Ana Blázquez (12 shared papers)
Journals: European Neuropsychopharmacology (8 papers)Psychiatry Research (7 papers)Translational Psychiatry (6 papers)Progress in Neuro-Psychopharmacology and Biological Psychiatry (5 papers)The Pharmacogenomics Journal (5 papers)
Partner nations: Spain United States United Kingdom

In The Last Decade

Sergi Mas

107 papers receiving 1.7k citations

Peers

Countries citing papers authored by Sergi Mas

Since Specialization

Citations

This map shows the geographic impact of Sergi Mas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergi Mas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergi Mas more than expected).

Fields of papers citing papers by Sergi Mas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergi Mas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergi Mas. The network helps show where Sergi Mas may publish in the future.

Co-authors

The 25 scholars most cited alongside Sergi Mas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sergi Mas Line = papers co-authored together Sergi Mas links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 115 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Evidence of activation of the Toll-like receptor-4 proinflammatory pathway in patients with schizophrenia Journal of Psychiatry and Neuroscience ·Borja García‐Bueno, Patricia Gassó, Karina S. MacDowell, Luís F. Callado, Sergi Mas, Miquel Bernardo, Amàlia Lafuente, J. Javier Meana, Juan C. Leza	2016	64
2	Neurotoxic/neuroprotective activity of haloperidol, risperidone and paliperidone in neuroblastoma cells Progress in Neuro-Psychopharmacology and Biological Psychiatry ·Patricia Gassó, Sergi Mas, Oriol Molina-Andreu, Miquel Bernardo, Amàlia Lafuente, Eduard Parellada	2011	55
3	Inflammatory dysregulation of monocytes in pediatric patients with obsessive-compulsive disorder Journal of Neuroinflammation ·Natàlia Rodríguez, Ástrid Morer, Europa Azucena González‐Navarro, Carles Serra‐Pages, Daniel Boloc, Teresa Torres, Susana García-Cerro, Sergi Mas, Patricia Gassó, Luisa Lázaro	2017	54
4	Exon-focused genome-wide association study of obsessive-compulsive disorder and shared polygenic risk with schizophrenia Translational Psychiatry ·Javier Costas, Noa Carrera, Pino Alonso, Xaquín Gurriarán, Cinto Segalàs, Eva Real, Clara López‐Solà, Sergi Mas, Patricia Gassó, Laura Domènech, Marta Morell, Inés Quintela, Luisa Lázaro, José M. Menchón, Xavier Estivill, Ãngel Carracedo	2016	45
5	A common variant in DRD3 gene is associated with risperidone-induced extrapyramidal symptoms The Pharmacogenomics Journal ·Patricia Gassó, Sergi Mas, Miquel Bernardo, S Álvarez, Eduard Parellada, A Lafuente	2009	42
6	Effects of milk supplementation with conjugated linoleic acid (isomers cis-9, trans-11 and trans-10, cis-12) on body composition and metabolic syndrome components British Journal Of Nutrition ·Nuria Laso, Emma Brugué, Josép Vidal, Emilio Ros, Joan Albert Arnáiz, Xavier Carné, Sergi Vidal, Sergi Mas, R. Deulofeu, Amàlia Lafuente	2007	41
7	Effect of CYP2D6, CYP2C9 and ABCB1 genotypes on fluoxetine plasma concentrations and clinical improvement in children and adolescent patients The Pharmacogenomics Journal ·Patricia Gassó, Natàlia Rodríguez, Sergi Mas, Mireia Pagerols, Ana Blázquez, María Teresa Plana, M. Torra, Luisa Lázaro, Amàlia Lafuente	2014	39
8	Modelling gene-environment interaction in first episodes of psychosis Schizophrenia Research ·Miquel Bernardo, Miquel Bioque, Bibiana Cabrera, António Lobo, Ana González‐Pinto, L. Pina, Iluminada Corripio, Julio Sanjuán, Anna Mané, Josefina Castro‐Fornieles, Eduard Vieta, Celso Arango, Gisela Mezquida, Patricia Gassó, Mara Parellada, Jerónimo Sáiz-Ruiz, Manuel J. Cuesta, Sergi Mas	2017	39
9	Increased susceptibility to apoptosis in cultured fibroblasts from antipsychotic-naïve first-episode schizophrenia patients Journal of Psychiatric Research ·Patricia Gassó, Sergi Mas, Oriol Molina-Andreu, Amàlia Lafuente, Miquel Bernardo, Eduard Parellada	2013	39
10	Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders Psychiatry Research ·Amàlia Lafuente, Miquel Bernardo, Sergi Mas, Anna Crescenti, Mònica Aparici, Patricia Gassó, R. Deulofeu, Anna Mané, Rosa Catalán, Xavier Carné	2008	39
11	Dopamine transporter (DAT) genotype (VNTR) and phenotype in extrapyramidal symptoms induced by antipsychotics Schizophrenia Research ·Amàlia Lafuente, Miquel Bernardo, Sergi Mas, Anna Crescenti, Mònica Aparici, Patricia Gassó, Rosa Catalán, J.J. Mateos, F. Lomeña, Eduard Parellada	2006	38
12	Pharmacogenetic predictors of angiotensin-converting enzyme inhibitor-induced cough Pharmacogenetics and Genomics ·Sergi Mas, Patricia Gassó, Santiago Álvarez, Jacint Ortiz, J Sotoca, Antonio Francino, Xavier Carné, Amàlia Lafuente	2011	38
13	Association between genetic variants related to glutamatergic, dopaminergic and neurodevelopment pathways and white matter microstructure in child and adolescent patients with obsessive–compulsive disorder Journal of Affective Disorders ·Patricia Gassó, Ana E. Ortiz, Sergi Mas, Ástrid Morer, Anna Calvo, Núria Bargalló, Amàlia Lafuente, Luisa Lázaro	2015	38
14	Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is associated with schizophrenia in a Spanish population Psychiatry Research ·Anna Crescenti, Patricia Gassó, Sergi Mas, Rosa Abellana, R. Deulofeu, Eduard Parellada, Miquel Bernardo, Amàlia Lafuente	2008	35
15	Intuitive pharmacogenetics: spontaneous risperidone dosage is related to CYP2D6, CYP3A5 and ABCB1 genotypes The Pharmacogenomics Journal ·Sergi Mas, Patricia Gassó, S Álvarez, Eduard Parellada, Miquel Bernardo, A Lafuente	2010	32
16	Common genetic background in anorexia nervosa and obsessive compulsive disorder: Preliminary results from an association study Journal of Psychiatric Research ·Sergi Mas, María Teresa Plana, Josefina Castro‐Fornieles, Patricia Gassó, Amàlia Lafuente, Elena Moreno, Estebán Martínez, Montserrat Milà, Luisa Lázaro	2013	31
17	A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project The International Journal of Neuropsychopharmacology ·Miquel Bioque, Adrián LLerena, Bibiana Cabrera, Gisela Mezquida, António Lobo, Ana González‐Pinto, Covadonga M. Díaz‐Caneja, Iluminada Corripio, Eduardo J. Aguilar, Antoni Bulbena, Josefina Castro‐Fornieles, Eduard Vieta, Amàlia Lafuente, Sergi Mas, Mara Parellada, Jerónimo Sáiz-Ruiz, Manuel J. Cuesta, Miquel Bernardo, (unknown)	2015	29
18	Examining Gene–Environment Interactions Using Aggregate Scores in a First-Episode Psychosis Cohort Schizophrenia Bulletin ·Sergi Mas, Daniel Boloc, Natalia Rodríguez, Gisela Mezquida, Sílvia Amoretti, Manuel J. Cuesta, Javier González‐Peñas, Alicia García-Alcón, António Lobo, Ana González‐Pinto, Iluminada Corripio, Eduard Vieta, Josefina Castro‐Fornieles, Anna Mané, Pilar A. Sáiz, Patricia Gassó, Miquel Bioque, Miquel Bernardo, (unknown)	2020	29
19	DNA Cards: Determinants of DNA Yield and Quality in Collecting Genetic Samples for Pharmacogenetic Studies Basic & Clinical Pharmacology & Toxicology ·Sergi Mas, Anna Crescenti, Patricia Gassó, José Vidal, Amàlia Lafuente	2007	29
20	CYP2D63, 4, 5 AND 6 POLYMORPHISMS AND ANTIPSYCHOTIC‐INDUCED EXTRAPYRAMIDAL SIDE‐EFFECTS IN PATIENTS RECEIVING ANTIPSYCHOTIC THERAPY Clinical and Experimental Pharmacology and Physiology ·Anna Crescenti, Sergi Mas, Patricia Gassó, Eduard Parellada, Miquel Bernardo, Amàlia Lafuente	2008	29

About Sergi Mas

Sergi Mas is a scholar working on Psychiatry and Mental health, Molecular Biology, Genetics, Cellular and Molecular Neuroscience and Clinical Psychology, having authored 115 papers that have together received 1.8k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (32 papers), Bipolar Disorder and Treatment (23 papers), Genetic Associations and Epidemiology (20 papers), Tryptophan and brain disorders (16 papers), Obsessive-Compulsive Spectrum Disorders (15 papers), Neuroscience and Neuropharmacology Research (10 papers), Pharmacogenetics and Drug Metabolism (10 papers) and Autism Spectrum Disorder Research (10 papers). The work is most often cited by research in Biological Psychiatry (230 citations), Psychiatry and Mental health (530 citations), Pharmacology (187 citations), Behavioral Neuroscience (65 citations) and Clinical Psychology (344 citations). Sergi Mas has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Patricia Gassó, Amàlia Lafuente, Miquel Bernardo, Eduard Parellada, Luisa Lázaro, Natàlia Rodríguez, Anna Crescenti, Ana Blázquez, Ástrid Morer and Joan Albert Arnáiz. Their work appears in journals such as European Neuropsychopharmacology, Psychiatry Research, Translational Psychiatry, Progress in Neuro-Psychopharmacology and Biological Psychiatry and The Pharmacogenomics Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact